Additionally, cluster 2 was also significantly associated with gender (p = 0.015), HER2 positive (p < 0.001), and triple-negative breast cancer (p = 0.005), but not BRCA1, BRCA2, ER, and PR (p > 0.05). This evidence concerns the gene BRCA1 and triple-negative breast carcinoma.